28 studies found for:    " November 01, 2009":" December 01, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Unknown  HIV Persistence and Viral Reservoirs
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir, tenofovir/emtricitabine
2 Unknown  A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
Condition: HIV Infections
Interventions: Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
3 Unknown  Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya
Condition: HIV Infections
Interventions: Other: CARE+ Kenya brief computer risk assessment session;   Other: CARE+ Kenya computer counseling session
4 Unknown  HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
5 Active, not recruiting Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.
Condition: HIV Infections
Intervention: Drug: Efavirenz
6 Completed Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: AERAS-402;   Biological: Placebo Control
7 Terminated Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
Intervention:
8 Recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
9 Terminated Appropriate Timing of HAART in Co-infected HIV/TB Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: tenofovir, lamivudine, efavirenz
10 Completed Cardiovascular Risk Evaluation and Antiretrovirals in HIV
Conditions: Cardiovascular Risk;   HIV Infections
Intervention:
11 Completed
Has Results
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Conditions: Hypertriglyceridemia;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
12 Completed Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Adjuvanted influenza A(H1N1) vaccines
13 Completed Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
Condition: HIV Infections
Interventions: Biological: adjuvanted A(H1N1)v influenza vaccine;   Biological: non-adjuvanted A(H1N1)v influenza vaccine
14 Completed Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Conditions: HIV Infection;   Liver Failure;   Evidence of Liver Transplantation
Intervention: Drug: Raltegravir potassium
15 Terminated Observational Study on Anti-tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
Condition: HIV Infection
Intervention:
16 Completed Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1
Condition: HIV-1 Infections
Intervention: Drug: BMS-663068 with or without ritonavir
17 Completed Exploration of HIV Reservoirs
Condition: HIV-1 Infection
Intervention: Procedure: Rectal mucosa biopsy
18 Completed Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression
Condition: Human Immunodeficiency Virus
Intervention:
19 Active, not recruiting CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Condition: HIV-1 Infections
Interventions: Drug: IL-2 (~1.2M IU/m2);   Biological: T Cell infusion 5-10 x E9 T cells
20 Recruiting Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Conditions: AIDS-related Kaposi Sarcoma;   HIV Infection;   Recurrent Kaposi Sarcoma
Interventions: Drug: bortezomib;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
Indicates status has not been verified in more than two years